Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:46 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Listen: Spotify Apple Podcasts Isomorphic Labs announces a cross-modality, multi-target research collaboration with Johnson & Johnson. This partnership brings together Iso’s AI-first approach to drug discovery with Johnson & Johnson’s expertise in drug discovery and development. Isomorphic Labs’ foundational drug design engine is capable of generating drug candidates against challenging targets ac
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.